Skip to main content
Premium Trial:

Request an Annual Quote

John Abeles, Shelly Gunn, Aaron Bensimon

John Abeles has joined CombiMatrix’s Scientific Advisory Board, CombiMatrix parent company Acacia Research said.
Abeles practiced medicine in London before becoming a senior executive in Pfizer, Sterling Drug, and Revlon Health Care. He was a healthcare analyst with Kidder Peabody and later formed MedVest, a healthcare consulting firm.
Abeles received his medical degree as well as a degree in pharmacology from the University of Birmingham, UK.
Additionally, CombiMatrix has hired Shelly Gunn as a medical director for its CombiMatrix Molecular Diagnostics unit.
Gunn earned her BA and Master's degrees from Trinity University. She received her MD and PhD degrees from the University of Texas Health Science Center at San Antonio Graduate School of Biomedical Sciences.

Genomic Vision this week said that it had named Aaron Bensimon as president and CEO. Bensimon earned his PhD in molecular biology from the Weizmann Institute of Science in Israel, and has been head of the Genome Stability Unit at the Institut Pasteur since 1994. He developed Genomic Vision’s molecular combing technology at the Statistical Physics Laboratory of the Ecole Normale Supérieure in Paris, and holds 13 patents in the technology.

Filed under

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.